Description:
2027 Bioshares Biotech Summit
Presentations that have been released from the 21st Bioshares Biotech Summit are provided below.
Acrux
Actinogen Medical
Amplia Therapeutics
Aroa Biosurgery (James Agnew)
BCAL Diagnostics
Clarity Pharmaceuticals
Cogstate
Dimerix
Entropy Neurodynamics
FivepHusion
Imunexus Therapeutics
Island Pharmaceuticals
Lateral Pharma (Contact David directly: dk@lateral-pharma.com)
Lumos Diagnostics
Mayne Pharma
Neuren Pharmaceuticals
Rhythm Biosciences
Vectus Biosystems
Congratulations to Brad O'Connor, Martyn Myer and the Cogstate team who were recipients of the Blake Award for Excellence this year.
A big thank-you to the sponsors who backed this event: Investment banks E&P and Bell Potter Securities, CFO services group Bio101, the ASX, the sector insurer Liberty Specialty Markets, Avatar Brokers, the global CRO IQVIA Biotech, Australian R&D finance group Endpoints Capital, At-the-Market finance group Acuity Capital, the leading sector IP firm FB Rice, investor engagement firm InvestorHub, and long standing supporter of the Summit, law firm Piper Alderman. And also to the support of our media partner, NWR Communications.
And a thank-you to all of our presenters, including our Key Note Speakers Brian Ward and David Williams, and sessions chairs, as well as to Brian Leedman for organising the Endpoints Capital Cup golf day.
Next year the event returns to Hobart, with dates to be confirmed.
Kind regards,
Mark Pachacz
Bioshares
bioshares1[at]gmail.com
0403-850-425
